Reply: Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials

被引：0
作者：
Su, Jingyang [1 ]
Fu, Yue [1 ]
Wang, Menglei [1 ]
Lin, Shengyou [2 ]
机构：
[1] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Hangzhou, Peoples R China
[2] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Dept Oncolgy, 453 Tiyuchang Rd, Hangzhou 310000, Peoples R China
来源：
CLINICAL ENDOCRINOLOGY | 2023年 / 98卷 / 02期
关键词：
lenvatinib; meta-analysis; radioiodine-refractory thyroid carcinoma; systematic review;
D O I：
10.1111/cen.14718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 276
页数：2
相关论文
共 5 条
[1]   Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial [J].
Kiyota, Naomi ;
Robinson, Bruce ;
Shah, Manisha ;
Hoff, Ana O. ;
Taylor, Matthew H. ;
Li, Di ;
Dutcus, Corina E. ;
Lee, Eun Kyung ;
Kim, Sung-Bae ;
Tahara, Makoto .
THYROID, 2017, 27 (09) :1135-1141
[2]   Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer [J].
Kiyota, Naomi ;
Schlumberger, Martin ;
Muro, Kei ;
Ando, Yuichi ;
Takahashi, Shunji ;
Kawai, Yasukazu ;
Wirth, Lori ;
Robinson, Bruce ;
Sherman, Steven ;
Suzuki, Takuya ;
Fujino, Katsuki ;
Gupta, Anubha ;
Hayato, Seiichi ;
Tahara, Makoto .
CANCER SCIENCE, 2015, 106 (12) :1714-1721
[3]   Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer [J].
Schlumberger, Martin ;
Tahara, Makoto ;
Wirth, Lori J. ;
Robinson, Bruce ;
Brose, Marcia S. ;
Elisei, Rossella ;
Habra, Mouhammed Amir ;
Newbold, Kate ;
Shah, Manisha H. ;
Hoff, Ana O. ;
Gianoukakis, Andrew G. ;
Kiyota, Naomi ;
Taylor, Matthew H. ;
Kim, Sung-Bae ;
Krzyzanowska, Monika K. ;
Dutcus, Corina E. ;
de las Heras, Begona ;
Zhu, Junming ;
Sherman, Steven I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) :621-630
[4]   Treatment-Emergent Hypertension and Efficacy in the Phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (SELECT) [J].
Wirth, Lori J. ;
Tahara, Makoto ;
Robinson, Bruce ;
Francis, Sanjeev ;
Brose, Marcia S. ;
Habra, Mouhammed Amir ;
Newbold, Kate ;
Kiyota, Naomi ;
Dutcus, Corina E. ;
Mathias, Elton ;
Guo, Matthew ;
Sherman, Steven I. ;
Schlumberger, Martin .
CANCER, 2018, 124 (11) :2365-2372
[5]   Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials [J].
Yan, Zhipeng ;
Yang, Ming ;
Lai, Ching-Lung .
CLINICAL ENDOCRINOLOGY, 2021, 95 (03) :478-488
1